scholarly article | Q13442814 |
P2093 | author name string | U. Veronesi | |
J. Lacour | |||
C. Rumeau-Rouquette | |||
P. Bucalossi | |||
M. Le | |||
T. Koszarowski | |||
E. Cacers | |||
G. Jacobelli | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oncology | Q162555 |
P304 | page(s) | 206-214 | |
P577 | publication date | 1976-01-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study | |
P478 | volume | 37 |
Q40555646 | A Status Report on the Management of Solid Tumours |
Q53048449 | A comparison between the results of simple mastectomy and tumorectomy for breast cancer: the problem of local recurrence. |
Q74403084 | A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer |
Q43535640 | A new method of modified radical mastectomy for breast cancer |
Q71785449 | A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients |
Q69805368 | Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: a comparison of CMFVP versus L-PAM |
Q41433704 | Adjuvant irradiation for early breast cancer an on-going controversy |
Q71043766 | Adjuvant radiotherapy in operable breast cancer: Correlation between dose in internal mammary nodes and prognosis |
Q40779605 | Adjuvant radiotherapy trials in breast cancer |
Q36919656 | Axillary surgery in breast cancer patients |
Q37056935 | Breast Magnetic Resonance Imaging for Assessment of Internal Mammary Lymph Node Status in Breast Cancer |
Q36302102 | Breast cancer: from "maximum tolerable" to "minimum effective" treatment |
Q35743986 | Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy |
Q34713794 | Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control |
Q50877812 | Comparisons of Positron Emission Tomography/Computed Tomography and Ultrasound Imaging for Detection of Internal Mammary Lymph Node Metastases in Patients With Breast Cancer and Pathologic Correlation by Ultrasound-Guided Biopsy Procedures. |
Q34439046 | Comprehensive review of the management of internal mammary lymph node metastases in breast cancer |
Q73223977 | Controversies in the Surgical Management of Operable Breast Cancer |
Q81136409 | Does primary tumor location have prognostic significance in operable breast cancer? |
Q35014628 | Does regional treatment improve the survival in patients with operable breast cancer? |
Q90587535 | Dosimetric comparison of incidental radiation to the internal mammary nodes after breast-conserving surgery using 3 techniques-inverse intensity-modulated radiotherapy, field-in-field intensity-modulated radiotherapy, and 3-dimensional conformal rad |
Q38617593 | Early breast cancer. A review |
Q39779871 | Early breast cancer: Part I: Surgical pathology and preoperative assessment |
Q39779874 | Early breast cancer: Part II. Management |
Q45109443 | Extended surgery for gastric cancer: an historical commentary |
Q69233142 | Five year results of radical mastectomy for breast cancer, by a sternal splitting, intrapleural en bloc resection of the internal mammary lymph nodes |
Q71995605 | Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer |
Q85055732 | How do I deal with the axilla in patients with a positive sentinel lymph node? |
Q36624145 | Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients |
Q35918806 | Incidence and Potential Significance of Internal Mammary Lymphadenopathy on Computed Tomography in Patients with a Diagnosis of Primary Breast Cancer. |
Q33685009 | Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer |
Q73915249 | Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer |
Q39384756 | Internal mammary node status: a major prognosticator in axillary node-negative breast cancer |
Q79241098 | Internal mammary sentinel nodes in primary breast cancer |
Q52950362 | Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. |
Q39211562 | Is there a rationale for an extended radical procedure? |
Q39742091 | Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy |
Q30569178 | Local and regional staging of invasive breast cancer with sonography: 25 years of practice at MD Anderson Cancer Center |
Q71380458 | Local excision and radiation therapy for early stage breast cancer |
Q52570072 | Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes |
Q50522177 | Lymphatic mapping and sentinel node biopsy in breast cancer. |
Q68569291 | Male breast cancer |
Q33779178 | Management of the axilla in primary breast cancer |
Q28345620 | Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye |
Q57580063 | N3 category in the TNM classification of breast cancer needs to be defined more precisely |
Q34138174 | NEO adjuvant chemotherapy in breast cancer: What have we learned so far? |
Q33287372 | Natural history of human breast cancer: Recent data and clinical implications |
Q40834000 | New clinical trends in the adjuvant therapy of early stage breast cancer |
Q35237209 | Operable breast cancer of the inner hemisphere is associated with poor survival |
Q71877345 | Optimizing radiotherapy of the internal mammary chain in breast carcinoma by scintigraphy |
Q46012628 | Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients |
Q68056231 | Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials |
Q33667619 | Postmastectomy radiation therapy: A surgical perspective |
Q26823624 | Postmastectomy radiation therapy: an overview for the practicing surgeon |
Q34397789 | Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes |
Q77911483 | Postmastectomy radiotherapy: randomized trials |
Q39622555 | Preoperative radiotherapy in operable breast cancer.Results in the Stockholm breast cancer trial |
Q35212604 | Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review |
Q36587890 | Radiation therapy after breast-conserving surgery |
Q37272657 | Radiation therapy for operable breast cancer: sixty years of progress as seen through the articles published in the journal Cancer |
Q70244841 | Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer |
Q36805818 | Radical versus modified radical mastectomy for breast cancer |
Q41791212 | Radiotherapy in the Therapeutic Strategy to Breast Cancer |
Q72569060 | Reappraisal of internal mammary lymph node dissection in selected patients with invasive breast cancer |
Q71093623 | Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients |
Q33972653 | Role of axillary surgery in early breast cancer: review of the current evidence |
Q43719379 | Sedation for CT examinations in children |
Q37970415 | Selection of breast-preservation therapy for primary invasive breast carcinoma |
Q40224034 | Selective avoidance of lymphatic irradiation in the conservative management of breast cancer |
Q50490190 | Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. |
Q74127626 | Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer |
Q44606330 | Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization |
Q33855425 | Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? |
Q41155888 | Strategies for the Advancement of Surgical Methods in Cleft Lip and Palate |
Q40197946 | Surgery and radiotherapy for primary breast cancer. What we have learned from the controlled clinical trials. |
Q41598552 | Surgery in the primary treatment of breast cancer |
Q70313299 | Surgical clinical trials |
Q36611787 | Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer |
Q40875920 | The application of clinical trials to solid tumour management: an introduction |
Q41098146 | The biologic and clinical significance of lymphatic metastases in breast cancer. |
Q38049474 | The changing face of mastectomy: an oncologic and cosmetic perspective |
Q52991028 | The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patients. |
Q40175502 | The contribution of regional lymph nodes in the resistance against breast cancer: Practical implications |
Q73409044 | The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial |
Q34041985 | The impact of loco-regional radiotherapy on the survival of breast cancer patients. Contra |
Q40999442 | The impact of surgery on breast cancer |
Q43774018 | The link between local recurrence and distant metastases in human breast cancer |
Q36467778 | The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases |
Q73711054 | The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1) |
Q69916055 | The revolution in breast cancer surgery: science or anecdotalism? |
Q69630913 | The significance of regional lymph node dissection in the surgical management of breast cancer |
Q72939424 | The significance of the internal mammary lymph nodes in medially located breast cancer |
Q95262714 | The study of internal mammary lymph node dissection guided by modified radiotracer injection technique in breast cancer-a case report and review |
Q44227235 | Thoracoscopic internal mammary lymph node dissection: a video demonstration |
Q37121284 | Treatment of Early Breast Cancer with Conservation of the Breast a Review |
Q37520419 | Validation study for the hypothesis of internal mammary sentinel lymph node lymphatic drainage in breast cancer |
Q34859352 | Will early detection of non-axillary sentinel nodes affect treatment decisions? |
Q73609479 | [Postmastectomy locoregional radiotherapy for breast cancer: literature review] |